Concepedia

Viral Vyas

VV

Statistics

Publications

16

Citations

766

H-Index

14

Active since

1998

Affiliations

Bristol-Myers Squibb (United States)(Current)

Rutgers, The State University of New Jersey

Johnson University

Bristol-Myers Squibb (Germany)

Rutgers Cancer Institute

Viral Vyas is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, pharmacy, and chemotherapy.

ORCID

Publications per year

1998–2009

16

Publications

16

Discovery and Preclinical Studies of (<i>R</i>)-1-(4-(4-Fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5- methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an In Vivo Active Potent VEGFR-2 Inhibitor

Rajeev S. Bhide, Zhen‐Wei Cai, Yong‐Zheng Zhang et al. · Journal of Medicinal Chemistry · 2006 · 133 citations · Full text

, , +15

Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections

Aberra Fura, Ashish K. Khanna, Viral Vyas et al. · Drug Metabolism and Disposition · 2009 · 99 citations

, , +14

Design, Synthesis, and Evaluation of Orally Active 4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazines as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Inhibitors

R. M. Borzilleri, Xiaoping Zheng, Ligang Qian et al. · Journal of Medicinal Chemistry · 2005 · 63 citations · Full text

, , +16

Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2)

Anita Lalloo, Feng Luo, Ailan Guo et al. · BMC Medicine · 2004 · 61 citations · Full text

, , +17

In vitro activation of irinotecan to SN-38 by human liver and intestine.

Farheena Ahmed, Viral Vyas, A. H. Cornfield et al. · PubMed · 1999 · 57 citations

, , +16

1–5 of 16